{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:36:12Z","timestamp":1744716972659},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2020,12,1]]},"DOI":"10.1001\/jamadermatol.2020.4380","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T16:47:02Z","timestamp":1604508422000},"page":"1380","source":"Crossref","is-referenced-by-count":5,"title":["Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy"],"prefix":"10.1001","volume":"156","author":[{"given":"Dustin H.","family":"Marks","sequence":"first","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Mansh","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Minnesota, Minneapolis"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"dle200008r1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials.","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"6","key":"dle200008r2","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/jamadermatol.2020.0464","article-title":"A new class of topical acne treatment addressing the hormonal pathogenesis of acne.","volume":"156","author":"Barbieri","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"1","key":"dle200008r3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jsm.12366","article-title":"Short- and long-term clinical skin effects of testosterone treatment in trans men.","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"1","key":"dle200008r4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/bjd.2019.180.issue-1","article-title":"Acne: a side effect of masculinizing hormonal therapy in transgender patients.","volume":"180","author":"Motosko","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"dle200008r5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/jamadermatol.2018.3909","article-title":"Improving dermatologic care for sexual and gender minority patients through routine sexual orientation and gender identity data collection.","volume":"155","author":"Mansh","year":"2019","journal-title":"JAMA Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2772466\/jamadermatology_marks_2020_le_200008_1607046270.46985.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T01:22:30Z","timestamp":1607563350000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2772466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2020.4380","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}